To evaluate the contribution of STAT3 activation in type I collagen-expressing fibroblasts during the development of experimental CRC, we crossbred Col1a2-CreERT2 with R26Stat3CSTOPfl/fl mice [32]. The gene discussed is COL1A2; the disease is colorectal carcinoma.